Epoxyeicosatrienoic acids, hypertension, and kidney injury.
作者信息
Imig John D
机构信息
From the Department of Pharmacology and Toxicology, Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee.
出版信息
Hypertension. 2015 Mar;65(3):476-82. doi: 10.1161/HYPERTENSIONAHA.114.03585. Epub 2015 Jan 12.
Abstract
摘要
相似文献
1
Epoxyeicosatrienoic acids, hypertension, and kidney injury.
Hypertension. 2015 Mar;65(3):476-82. doi: 10.1161/HYPERTENSIONAHA.114.03585. Epub 2015 Jan 12.
2
Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertension-induced end-organ damage in Ren-2 transgenic rats.
Clin Sci (Lond). 2010 Feb 23;118(10):617-32. doi: 10.1042/CS20090459.
3
Epoxyeicosatrienoic acids--novel mechanism and pharmacological therapy of chronic renocardiac syndrome.
Med Hypotheses. 2011 Apr;76(4):550-2. doi: 10.1016/j.mehy.2010.12.015. Epub 2011 Feb 18.
4
Preventing renal disease progression: is it the drug or the blood pressure reduction, or both?
Curr Hypertens Rep. 2000 Dec;2(6):497-9. doi: 10.1007/s11906-996-0030-y.
5
Orally Active Epoxyeicosatrienoic Acid Analogs.
J Cardiovasc Pharmacol. 2017 Oct;70(4):211-224. doi: 10.1097/FJC.0000000000000523.
6
The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.
Clin Exp Nephrol. 2009 Feb;13(1):96-9. doi: 10.1007/s10157-008-0128-4. Epub 2009 Jan 28.
7
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.
J Hum Hypertens. 2014 Feb;28(2):74-9. doi: 10.1038/jhh.2013.55. Epub 2013 Jun 27.
8
Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.
Hypertension. 2020 Jul;76(1):3-15. doi: 10.1161/HYPERTENSIONAHA.120.13898. Epub 2020 Jun 1.
9
Barnidipine ameliorates the vascular and renal injury in L-NAME-induced hypertensive rats.
Eur J Pharmacol. 2015 Oct 5;764:433-442. doi: 10.1016/j.ejphar.2015.07.033. Epub 2015 Jul 14.
10
New role for epoxyeicosatrienoic acids as anti-inflammatory mediators.
Trends Pharmacol Sci. 2000 Apr;21(4):125-7. doi: 10.1016/s0165-6147(00)01472-3.
引用本文的文献
1
Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition.
Front Pharmacol. 2024 Mar 8;15:1365802. doi: 10.3389/fphar.2024.1365802. eCollection 2024.
2
Association of CYP2C19 Polymorphic Markers with Cardiovascular Disease Risk Factors in Gas Industry Workers Undergoing Periodic Medical Examinations.
High Blood Press Cardiovasc Prev. 2023 Mar;30(2):151-165. doi: 10.1007/s40292-023-00567-4. Epub 2023 Feb 25.
3
Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury.
Adv Pharmacol. 2022;94:27-55. doi: 10.1016/bs.apha.2022.02.004. Epub 2022 Mar 30.
4
Pregnane X Receptor‒4β-Hydroxycholesterol Axis in the Regulation of Overweight- and Obesity-Induced Hypertension.
J Am Heart Assoc. 2022 Mar 15;11(6):e023492. doi: 10.1161/JAHA.121.023492. Epub 2022 Mar 1.
5
Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats.
Front Pharmacol. 2022 Jan 17;12:798642. doi: 10.3389/fphar.2021.798642. eCollection 2021.
6
Regioselective and Stereoselective Epoxidation of n-3 and n-6 Fatty Acids by Fungal Peroxygenases.
Antioxidants (Basel). 2021 Nov 25;10(12):1888. doi: 10.3390/antiox10121888.
7
GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans.
Hypertension. 2021 Sep;78(4):1092-1102. doi: 10.1161/HYPERTENSIONAHA.121.17659. Epub 2021 Aug 30.
8
Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review.
Arh Hig Rada Toksikol. 2021 Jun 28;72(3):114-128. doi: 10.2478/aiht-2021-72-3549.
9
Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of .
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1049-1055. doi: 10.1080/14756366.2021.1927005.
10
Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats.
Front Physiol. 2021 Jan 28;12:622882. doi: 10.3389/fphys.2021.622882. eCollection 2021.
本文引用的文献
1
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Hypertension. 2014 Nov;64(5):1012-21. doi: 10.1161/HYPERTENSIONAHA.114.03850. Epub 2014 Aug 4.
2
Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.
Hypertension. 2014 Dec;64(6):1275-81. doi: 10.1161/HYPERTENSIONAHA.114.03863. Epub 2014 Sep 2.
3
Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.
Am J Physiol Renal Physiol. 2014 Oct 15;307(8):F971-80. doi: 10.1152/ajprenal.00256.2014. Epub 2014 Aug 27.
4
14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) surrogates: carboxylate modifications.
J Med Chem. 2014 Aug 28;57(16):6965-72. doi: 10.1021/jm500262m. Epub 2014 Aug 19.
5
Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis.
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):11127-32. doi: 10.1073/pnas.1410432111. Epub 2014 Jul 14.
6
Sex differences in blood pressure control in SHR: lack of a role for EETs.
Physiol Rep. 2014 May 20;2(5). doi: 10.14814/phy2.12022. Print 2014 May 1.
7
Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α-linolenic acid-induced inhibition of soluble epoxide hydrolase.
Hypertension. 2014 Jul;64(1):53-9. doi: 10.1161/HYPERTENSIONAHA.114.03179. Epub 2014 Apr 28.
8
The biological actions of 11,12-epoxyeicosatrienoic acid in endothelial cells are specific to the R/S-enantiomer and require the G(s) protein.
J Pharmacol Exp Ther. 2014 Jul;350(1):14-21. doi: 10.1124/jpet.114.214254. Epub 2014 Apr 24.
9
Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition.
Clin Sci (Lond). 2014 Oct;127(7):463-74. doi: 10.1042/CS20130479.
10
Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.
J Lipid Res. 2014 Jun;55(6):1150-64. doi: 10.1194/jlr.M047357. Epub 2014 Mar 16.
Zotero 插件